Navigation Links
Orion Pharma Selects ChemDiv as A Partner in Drug Discovery Services
Date:11/30/2007

SAN DIEGO, Nov. 30 /PRNewswire/ -- ChemDiv, Inc. and Orion Pharma today announced that Orion has chosen ChemDiv as a discovery partner in small molecule therapeutics for Orion's priority targets.

Under the terms of the agreement, ChemDiv will deploy the Discovery outSource(TM) platform for Orion's discovery program, including the world's largest commercially available chemical library, proprietary rational design, assay development, and bioscreening. ChemDiv will screen rationally designed chemical libraries against Orion's proprietary targets, and Orion will select hit series for subsequent lead optimization. Financial terms and identity of drug targets were not disclosed. The agreement provides options for expanding the discovery partnership.

"I am very satisfied with the commitment and exchange of information in our joint effort. We have a good basis for success," said Dr. Ari Koivisto, Orion's contact person in the collaboration. "Our partnership with ChemDiv complements our in-house discovery effort in this particular project," stated Dr. Antti Haapalinna, Director of Nonclinical R&D, Orion Pharma, Orion Corporation.

"We are delighted to offer discovery services to Orion Pharma in this partnership. We are especially pleased with the constructive dialog with Orion R&D, based on our mutual understanding and shared goals. Based on ChemDiv's diligence and track record, we are confident of success and look forward to expansion of this collaboration in the near future," commented Nikolay Savchuk, President and CEO of ChemDiv, Inc.

About Orion Corporation

Orion Corporation (OMX: ORNAV, ORNBV) is one of the leading pharmaceutical companies in the northern Europe. Orion develops, manufactures and markets pharmaceuticals, active pharmaceutical ingredients and diagnostic tests for global markets. Pharmaceuticals generate about 95% of the Group's net sales, of which proprietary patented pharmaceutical innovations contribute a consi
'/>"/>

SOURCE ChemDiv, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Orion ICG, LLC Announces Acquisition of Cumberland Therapy Services, Inc.
2. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
3. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
4. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
7. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
9. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
10. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
11. Simcere Pharmaceutical Group Acquires a 51% Stake in Boda Pharmaceutical Co., Ltd.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... 15 In today,s academic medical centers, ... ever. Now the University HealthSystem Consortium (UHC) has ... Analysis: Achieving Cost Efficiencies in Health Care, ... environments. These new materials, developed with the input ... a practical guide to planning, implementing, and managing ...
(Date:12/14/2009)... ATLANTA, Dec. 14 Americold Realty Trust ("Americold") ... on Form S-11 with the U.S. Securities and Exchange ... offering of its common shares. The number of shares ... offering have not yet been determined. The common shares ... be sold by Americold. ,, The joint book-running ...
(Date:12/14/2009)... Dental Care (also known as Culver City Dentist ... care in Southern California. We provide treatments in general ... and periodontal treatments. Beverly Hills Dentist and ... with experienced and trusted dentists who provide these treatments ... is one of these trusted dentists. He is best ...
(Date:12/14/2009)... Sedwitz Heads up 900-Member Physician Staff , ... La ... Jolla have elected Marc Sedwitz, MD, as the new chief of ... head of the 900-member physician team on Jan. 1, 2010. , ... as medical staff liaison to Scripps La Jolla’s administrative staff and ...
(Date:12/14/2009)... Calif., Dec. 14 Grubb & Ellis Healthcare REIT ... authorized a daily distribution to stockholders of record as of ... commencing on Jan. 1, 2010 and ending on Feb. 28, ... days in the calendar year and will be equal to ... price of $10.00 per share. These distributions will be ...
Breaking Medicine News(10 mins):Health News:University HealthSystem Consortium Offers Value Analysis Professionals Insightful New Resources 2Health News:Americold Realty Trust Files Registration Statement for Proposed Initial Public Offering 2Health News:United Dental Care, Gentle Care, Trusted Dentists 2Health News:United Dental Care, Gentle Care, Trusted Dentists 3Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 2Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 3Health News:Grubb & Ellis Healthcare REIT II Declares Initial Distribution 2Health News:Grubb & Ellis Healthcare REIT II Declares Initial Distribution 3
... 4 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX :,HAE), ... plasma-derived protein products for commercialization,announces that it ... fractionation,facility for the production of its proprietary ... clinical trials, leading to commercial launch., ...
... BasicPlus Health,Insurance of Roswell, Ga., announced today that ... Healthcare Inc. of Columbia, S.C., to,include a network ... benefit health insurance plans., The agreement means ... (for individuals) limited benefit plans have the,option of ...
... New e-book outlines major issues and best practices for handling fresh, produce ... ... to know., ATLANTA, June 4 Fresh ... have raised public awareness and,industry concern. At its biennial meeting in San ...
... Bethesda, MD The American Society for Investigative ... M. Engman, MD, PhD, Professor of Pathology and ... of the ASIP - Amgen Outstanding Investigative Award, ... experimental pathology funded by Amgen. Dr. Engman ...
... Licensed pesticide applicators who used chlorinated pesticides on more ... risk of diabetes, according to researchers from the National ... and incident diabetes ranged from a 20 percent to ... with the NIH,s National Institute of Environmental Health Sciences ...
... Unilens Vision Inc. (OTC,Bulletin Board: UVICF; ... distributes and markets specialty contact lenses,today revealed ... GP (Gas Permeable),products., Unilens, known as ... continues its tradition of providing outstanding programs,designed ...
Other Medicine News:Health News:Haemacure Achieves Major Milestone - Starts Processing Plasma in Its New Fractionation Facility 2Health News:Insurance Company Includes Global Network Option in Limited Benefit Plans 2Health News:Insurance Company Includes Global Network Option in Limited Benefit Plans 3Health News:Chemstar Corporation Publishes New Insights on Fresh Produce Safety From CFP Workshop 2Health News:Long-term pesticide exposure may increase risk of diabetes 2Health News:Long-term pesticide exposure may increase risk of diabetes 3Health News:Unilens Vision Announces New Policies Aimed at Increasing Eye Care Professionals Profitability 2
(Date:12/14/2009)... Dec. 14 When staff from a ... apply the difficult to adjust and uncomfortable cubital ... Professional Products, Inc. (PPI) to develop a superior ... orthopaedic solutions for nearly five decades, responded with ... ), which it announced today. Simple to ...
(Date:12/14/2009)... Dec. 14 ... a leading provider of tools and services for ... that it has completed the sale of Xenogen ... pre-clinical CRO services, to Taconic Farms, Inc. for ... Caliper as part of Caliper,s acquisition of Xenogen ...
(Date:12/14/2009)... Dec. 14 Travelers of Interstate 70 west ... become a bit more colorful when 10 multicolored art ... is named going home , will eventually include ... a graduate student at Herron School of Art and ... Public Life. ,, Eli Lilly and Company (NYSE: ...
Breaking Medicine Technology:New Cubital Tunnel Splint Specially Designed for Comfort and Less Cumbersome Fit 2Caliper Completes Strategic Sale of Small Animal Services Subsidiary to Taconic 2Caliper Completes Strategic Sale of Small Animal Services Subsidiary to Taconic 3Caliper Completes Strategic Sale of Small Animal Services Subsidiary to Taconic 4Public Art to Complete Transformation of Key Gateway into Indianapolis 2Public Art to Complete Transformation of Key Gateway into Indianapolis 3Public Art to Complete Transformation of Key Gateway into Indianapolis 4BIA Publishes White Paper 3A ISO 9000 Role in Document Review Emphasizes Quality Equals Defensibility 5183 1BIA Publishes White Paper 3A ISO 9000 Role in Document Review Emphasizes Quality Equals Defensibility 5183 2BIA Publishes White Paper 3A ISO 9000 Role in Document Review Emphasizes Quality Equals Defensibility 5183 3Glove Nation Launches Major Website Upgrade 14329 1Glove Nation Launches Major Website Upgrade 14329 2High Cost of Chronic Illness Spotlights Need for Case Management Professionals 58738 1High Cost of Chronic Illness Spotlights Need for Case Management Professionals 58738 2
... Proof-of-Principle Studies -, GAITHERSBURG, Md., April 3, ... announced that it has signed an agreement,with Merck ... the use of the Iomai needle-free immunostimulant patch., ... exclusive license. These,preclinical proof-of-principle studies will be conducted ...
... announced a,cash injection from Midroc New Technology AB who ... will be used for,the further development of DermaGen,s first ... clinical phase 2a study in patients with Atopic,Dermatitis (AD), ... further develop the company,s R & D pipeline., ...
Other Medicine Technology:Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch 2Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch 3DermaGen AB Receives Over 1 Million Euros From a New Share Issue 2DermaGen AB Receives Over 1 Million Euros From a New Share Issue 3
The TEW Cranial/Spinal Retractor is designed for posterior fossa or intraspinal microsurgery where retraction is required....
... Infuse Bone Graft represents an rhBMP-2 ... combined with a bovine-derived absorbable collagen sponge ... tapered fusion device is indicated for spinal ... degenerative disc disease (DDD) at one level ...
... dowels are threaded to dramatically ... and improve graft stability. Dense, ... blood cell saturation for osteogenesis. ... into the porous structure of ...
Lorenz 2.0 mm titanium system for the midface provides an excellent alternative to lower profile systems in areas of the midface where greater fixation is needed....
Medicine Products: